Patents by Inventor Scott Harbeson

Scott Harbeson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxazolidinone derivatives and methods of use
    Patent number: 8796267
    Abstract: This invention relates to novel N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide derivatives, their acceptable acid addition salts, solvates and hydrates. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by antimicrobial agents.
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: August 5, 2014
    Assignee: Concert Pharmaceuticals, Inc.
    Inventors: Roger Tung, Scott Harbeson
  • Substituted triazolo-pyridazine derivatives
    Patent number: 8003646
    Abstract: This invention relates to novel substituted triazolo-pyridazines, their derivatives, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an ?1-GABA-A receptor antagonist and/or a ?2, ?3 and ?5 GABA-A receptor agonist.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: August 23, 2011
    Assignee: Concert Pharmaceuticals Inc.
    Inventor: Scott Harbeson
  • SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES
    Publication number: 20100056529
    Abstract: This invention relates to novel substituted triazolo-pyridazines, their derivatives, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an ?1-GABA-A receptor antagonist and/or a ?2, ?3 and ?5 GABA-A receptor agonist.
    Type: Application
    Filed: August 28, 2009
    Publication date: March 4, 2010
    Applicant: Concert Pharmaceuticals Inc.
    Inventor: Scott Harbeson
  • DIBENZOTHIAZEPINE DERIVATIVES
    Publication number: 20090291152
    Abstract: This invention relates to novel 11-[4-[2-(2-Hydroxyethoxy)ethyl]piperazin-1-yl]dibenzo[b,f][1,4]thiazepine derivatives, their acceptable acid addition salts, solvates, hydrates and polymorphs thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by antagonists of seratonergic 5HT1A and 5HT2 receptors, dopaminergic D1 and D2 receptor, histaminergic H1 receptors, and/or adrenergic ?1 and ?2 receptors.
    Type: Application
    Filed: April 17, 2009
    Publication date: November 26, 2009
    Applicant: Concert Pharmaceuticals Inc.
    Inventors: Roger Tung, Scott Harbeson
  • 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use
    Publication number: 20090197899
    Abstract: This invention relates to novel 3-(dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide compounds, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering inhibitors of cyclic guanosine 3?,5?-monophosphate specific phosphodiesterase (cGMP-specific PDE), in particular PDE5.
    Type: Application
    Filed: February 4, 2009
    Publication date: August 6, 2009
    Applicant: Concert Pharmaceuticals Inc.
    Inventors: Roger Tung, Scott Harbeson
  • Oxazolidinone derivatives and methods of use
    Publication number: 20090093422
    Abstract: This invention relates to novel N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide derivatives, their acceptable acid addition salts, solvates and hydrates. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by antimicrobial agents.
    Type: Application
    Filed: June 17, 2008
    Publication date: April 9, 2009
    Inventors: Roger Tung, Scott Harbeson
  • OXAZOLIDINONE DERIVATIVES AND METHODS OF USE
    Publication number: 20080139563
    Abstract: This invention relates to novel N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide derivatives, their acceptable acid addition salts, solvates and hydrates. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by antimicrobial agents.
    Type: Application
    Filed: October 23, 2007
    Publication date: June 12, 2008
    Applicant: Concert Pharmaceuticals Inc.
    Inventors: Roger Tung, Scott Harbeson
  • Novel heterobicyclic compounds
    Publication number: 20080058351
    Abstract: This invention relates to novel pyrazolo-pyrimidine compounds and their use as analytical tools and in methods of treating neurological disorders, including sleep disorders such as insomnia.
    Type: Application
    Filed: June 29, 2007
    Publication date: March 6, 2008
    Applicant: Concert Pharmaceuticals Inc.
    Inventors: Roger Tung, Scott Harbeson
  • HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF GSK-3
    Publication number: 20070270420
    Abstract: The present invention relates to compounds of formula I useful as inhibitors of GSK-3 and Lck protein kinases. The present invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders, such as diabetes, Alzheimer's disease, and transplant rejection.
    Type: Application
    Filed: July 12, 2007
    Publication date: November 22, 2007
    Inventors: Scott Harbeson, Michael Arnost, Jeremy Green, Vladimir Savic
  • Aminofurazan compounds useful as protein kinase inhibitors
    Publication number: 20050148640
    Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Application
    Filed: August 20, 2004
    Publication date: July 7, 2005
    Inventors: Jon Come, Jeremy Green, Craig Marhefka, Scott Harbeson, Ly Pham
  • Amino-alkyl derivatives
    Publication number: 20050065339
    Abstract: The present invention relates to amino-alkyl derivatives for treating or preventing neuronal damage associated with neurological diseases. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage.
    Type: Application
    Filed: May 27, 2004
    Publication date: March 24, 2005
    Inventors: Scott Harbeson, Michael Mullican
  • Amino-alkyl derivatives
    Publication number: 20020111347
    Abstract: The present invention relates to amino-alkyl derivatives for treating or preventing neuronal damage associated with neurological diseases. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage.
    Type: Application
    Filed: January 3, 2002
    Publication date: August 15, 2002
    Inventors: Scott Harbeson, Michael Mullican